MERS coronavirus

MERS coronavirus

Last week, I received the French newsletter “Lettre des Français du Monde- ADFE” No. 101. An entire section has been devoted to the MERS coronavirus. Here is what it said: The MERS-CoV, raging mainly in the Middle East, has now affected South Korea and Thailand. This is the largest outbreak outside Saudi Arabia, where up until now the vast majority of cases have been reported.

When this contagion, similar to Severe Acute Respiratory Syndrome (SARS), emerged in the Republic of Korea, the World Health Organization (WHO) convened its Emergency Committee on June 17 to evaluate the situation. WHO stated the spread of MERS-CoV was “a wake up call for all countries” and attributed the outbreak to the “lack of knowledge” of health care staff and general public. No vaccine or specific treatment is currently available and care consists mainly in hospital intensive care or specialized units.

I want to clarify that Pao pereira, a broad-spectrum antiviral, has not been tested on coronaviruses, and there is no evidence of any effectiveness on those specific viruses. But since there is no specific treatment known today, it would be wise to bring a broad-spectrum antiviral when traveling to Asia.

A study on the effectiveness and lack of side effects of Pao pereira (PB 100) on the AIDS virus was published in 1994 (The pilot study was conducted on 10 patients, and not two as Wikipedia claims).
Tolerance and Feasibility of a 12-Month Therapy Using the Antiretroviral Agent PB100 in AIDS-Related Complex Patients. D.Donadio et al. Dtsch.Zschr.Onkol. 26, 6 (1994).

Over the years, we have received several testimonials about the effectiveness of our Pao on flus, fevers that is also consistent with its traditional use. As stated in “Livro verde das plantas medicinais e industriais do Brasil” (1965), the therapeutic usage of Pao pereira is described as follows: “It is an excellent tonic and powerful remedy against intermittent fevers.” We have also received positive testimonials regarding herpes and chikungunya viruses.

If you would like to share your story, please send it to the Beljanski Foundation!